2021
DOI: 10.1080/07391102.2021.1886993
|View full text |Cite
|
Sign up to set email alerts
|

Repurposing drugs and identification of inhibitors of integral proteins (spike protein and main protease) of SARS-CoV-2

Abstract: The outbreak of Coronavirus infection (COVID-19) has prompted the World Health Organisation (WHO) to declare the outbreak, a Public Health Emergency of International concern. As part of the efforts to discover lead compounds for clinical use, 53 molecules were screened using molecular docking and dynamic simulations (MDS) techniques to identify potential inhibitors of SARS-CoV-2 spike protein (COVID-19 S gp ) and main protease (COVID-19 M pro ) or both. Lopinavir (… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

3
23
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 22 publications
(26 citation statements)
references
References 52 publications
3
23
0
Order By: Relevance
“…Additionally, better poses were observed for epicatechin, luteolin-7- O -beta- d -glucoside, isorhamnetin-3- O -rutinoside, rutin, hyperoside and procyanidin with alpha-amylase compared to the resulting complexes with acarbose ( Table 3 ). While most of the identified compounds including 1,3-dicaffeoxyl quanic acid, chlorogenic acid, epicatechin, isorhamnetin-3- O -rutinoside, luteolin-7- O -beta- d -glucoside, myrcetin, rutin, cacticin, hyperoside and procyanidin showed good docking with alpha-glucosidase as depicted by the higher negative values than acarbose, other compounds (epicatechin, isorhamnetin-3- O -rutinoside, chlorogenic acid and rutin) had commendable binding at the active sites of the three enzymes ( Table 3 ), which is indicative of their prospective interaction with the enzymes [ 28 ]. However, since docking is only a preliminary reflection of the ligand’s fitness within the binding pocket of a receptor, the binding orientations of the studied phenolics were subjected to further binding energy calculations and MDS.…”
Section: Resultsmentioning
confidence: 99%
See 4 more Smart Citations
“…Additionally, better poses were observed for epicatechin, luteolin-7- O -beta- d -glucoside, isorhamnetin-3- O -rutinoside, rutin, hyperoside and procyanidin with alpha-amylase compared to the resulting complexes with acarbose ( Table 3 ). While most of the identified compounds including 1,3-dicaffeoxyl quanic acid, chlorogenic acid, epicatechin, isorhamnetin-3- O -rutinoside, luteolin-7- O -beta- d -glucoside, myrcetin, rutin, cacticin, hyperoside and procyanidin showed good docking with alpha-glucosidase as depicted by the higher negative values than acarbose, other compounds (epicatechin, isorhamnetin-3- O -rutinoside, chlorogenic acid and rutin) had commendable binding at the active sites of the three enzymes ( Table 3 ), which is indicative of their prospective interaction with the enzymes [ 28 ]. However, since docking is only a preliminary reflection of the ligand’s fitness within the binding pocket of a receptor, the binding orientations of the studied phenolics were subjected to further binding energy calculations and MDS.…”
Section: Resultsmentioning
confidence: 99%
“…The nature/extent of stability and convergence of a ligand-receptor system is normally measured by RMSD [ 28 ]. In this study, the average RMSD values for procyanidin, rutin and acarbose (standard drug) were 1.62 Å, 1.68 Å and 1.82 Å, respectively, while it was 2.04 Å for α-amylase (apo-enzyme) ( Figure 2 A).…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations